Uncovering the Truth: ISS Relies on MindMed’s Deceptive Statements to Excuse Poor Performance and Neglect of Patient Safety

ISS Dismissed 47% Stock Price Drop Following September 2022 Financing as In Line with “Sectoral Trends” In a Baffling Lack of Critical Analysis and Seemingly in Opposition to the Factual Circumstances After Recommending Removal of Chair Vallone in 2022, ISS Appears to Blindly Accept Vallone’s and MindMed’s Justifications for Poor Development Decisions, Destructive Financing, and……

Read More

Unlocking Success: How BIO-key Utilizes AWS Partner Network to Develop Cutting-Edge IAM Solutions in Europe, the Middle East, and Africa

BIO-key Leverages AWS Partner Network to Build Identity and Access Management (IAM) Solutions in Europe, the Middle East, and Africa Introduction Wall, N.J. and Madrid, Spain, June 05, 2023 – BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of Identity and Access Management (IAM) and Identity-Bound Biometric (IBB) solutions, and Amazon Web Services (AWS) Partner…

Read More

Meet the Newest Addition to Alpha Transform Holdings: Co-Chief Investment Officer Wes Levitt!

Welcome Wes Levitt to Alpha Transform Holdings! June 05, 2023 Bradenton, FL (GLOBE NEWSWIRE) Alpha Transform Holdings has made an exciting announcement today, welcoming Wes Levitt, CFA as the new Co-Chief Investment Officer. Mr. Levitt will be taking on the role of Co-CIO for the Alpha Transform Holdings Blockchain/Web3 Fund and Alpha Liquid Fund, where…

Read More

Unlocking the Potential of Decentralized Storage: A Look into Datamall Chain’s Impact from Three Perspectives

Exploring the Future of Decentralized Storage: How Datamall Chain Leads the Way from Three Perspectives The Rise of Decentralized Storage San Jose, CA, June 04, 2023 (GLOBE NEWSWIRE) — The past few years have seen a gradual increase in the market demand for decentralized storage. With the explosive growth of digital content and increasing concerns…

Read More

Unlocking the Power of Trilaciclib: Boosting Memory T-Cells for Stronger Immune Surveillance and Efficacy in Tumor Microenvironments

Phase 2 Mechanism of Action Trial Results Demonstrate the Immunomodulatory Effects of Trilaciclib in the Tumor Microenvironment Trilaciclib Enhances Expression of Genes Associated with Memory T Cells In a recent phase 2 clinical trial, the results have shown promising effects of Trilaciclib in modulating the tumor microenvironment. Trilaciclib, a novel drug, has been found to…

Read More

Breaking News: Attorney General Garland Named Worst Violator of Civil Liberties by NCLA’s King George III Award – But Don’t Worry, You’re Not Alone!

Welcome to the NCLA’s King George III Award Ceremony! Celebrating the “Worst Violator of Civil Liberties” By: A Playful and Quirky Blogger Hey there, lovely readers! Grab your popcorn and get ready for the juiciest news of the day. The New Civil Liberties Alliance has just crowned Attorney General Merrick Garland as the biggest abuser…

Read More